The stock market rebound led to Bed & Body Works (BBWI) on the verge of breaking out. The fragrance maker for the teenage market trades at a price-to-earnings multiple of below nine times.
BBWI stock has minimal exposure to its merchandise made in China. That will give the firm an edge over its competitors.
AbbVie (ABBV) solidified its leadership in the drug manufacturing space. The stock traded as low as $170 just before the firm posted quarterly results. Strong sales for its latest blockbuster drugs more than offset the patent cliff revenue drop for Humira.
Centene (CNC) shares are trading in the $60 range. The uptrend started on April 25, after the Medicaid firm posted $48.6 billion in revenue (20% Y/Y growth). CNC increased its premium and service revenue guidance for 2025. It expects $164 billion to $166 billion this year.
Erie Indemnity (ERIE) closed at levels not seen since June 2024. The revenue of $989.4 million (+12.3% Y/Y) is not strong enough, given the stock’s overvaluation.
Colgate-Palmolive (CL) shares risk breaking below the $90 support price. Tariffs created headwinds to its growth plans this year.
Watch Kraft Heinz (KHC) this morning. Investors will react to its earnings report posted before markets open.